News from biotuesdays.com
Top biotuesdays.com News

FDA · TorontoTORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce today that the U.S. Food and…See the Story
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
80% Left coverage: 10 sources

Pharma · United StatesNRX-100 receives FDA fast track designation, offering hope for treating suicidal ideation in depression and bipolar disorder, addressing a critical health crisis.See the Story
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
100% Center coverage: 2 sources
